2Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction(TIMI) trial, Phase I: A comparision between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation
3Sone T, Okumura K, Tsuboi H, et al. Angiographic no-flow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. JACC, 2000, 36:1202-1209.
4Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of ""no flow"" after percutaneous coronary intervention. Circulation, 1994,89:2514-2518.
5Abbo KM, Doris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol, 1995,75:778-782.
6Baumgent D, Haude M, Goerke G, et al. Improved assessment of coronary stenosis severity using the relative flow velocity reserve. Circulation, 1998,98:40-46.
7Hong MK, Mehran GS, Mintz GS, et al. Restenosis after coronary angioplasty. Curr Probl Cardiol, 1997,22:7-27.
8Eric E, Lukas K, Jean-Jacques G. Stent for intracoronary placement: Current status and future directions. J Am Coll Cardiol, 1996,27:757-765.
1Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality [ J]. Am J Cardiol, 2007, 99 (4) : 442-445.
2TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial [J]. N EnglJ Meal, 1985, 312 (14): 932-936.
3van't Hof AW, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade [J]. Circulation, 1998, 97 (23): 2302-2306.
4Rentrop KP, Cohen M, Blanke H, et al. Changes in coflateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjeets [ J ]. J Am Coll Cardiol, 1985, 5 (3): 587-592.
5Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy [ J ]. Circulation, 2001, 103 (21) : 2550-2554.
6Ndrepepa G, Mehilli J, Schulz S, et al. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes [ J ]. J Am Coil Cardiol, 2008, 52 (7): 512-517.
7Reffelnmann T, Kloner RA. The no-reflow phenomenon: Basic science and clinical correlates [J]. Heart, 2002, 87 (2) : 162-168.
8Lowe GD, Rumley A, Woodward M, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey I. Illustrative reference ranges by age, sex, and hormone use [J]. Br J Haematol, 1997, 97 (4) : 775- 784.
9Hearse DJ, Bolli R. Reperfusion induced injury: Manifestations, mechanisms, and clinical relevance [ J]. Cardiovasc Res, 1992, 26 (2): 101-108.
10Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction [J]. J Am Coll Cardiol, 2003, 41 (1): 1-7.
